Medtronic revenue hits $8B in latest quarter

Medical devicemaker Medtronic saw nearly $8.1 billion in revenue in its third quarter of fiscal year 2024, a 4.7% increase from the year earlier. 

Advertisement

In the three months ending Jan. 26, Medtronic recorded $8.09 billion in net sales. The growth from a year ago, which reported $7.73 billion in revenue, is attributed to Medtronic’s diabetes, core spine, cardiac surgery, structural heart and cardiac pacing services.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.